Published in Virol J on August 27, 2010
An overview of occult hepatitis B virus infection. World J Gastroenterol (2011) 1.32
Low frequency of occult hepatitis B infection in anti-HBc seropositive blood donors: experience from a tertiary care centre in South India. Blood Transfus (2011) 0.97
Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol (2013) 0.92
Potential mutations associated with occult hepatitis B virus status. Hepat Mon (2014) 0.87
A Bayesian meta-analysis on prevalence of hepatitis B virus infection among Chinese volunteer blood donors. PLoS One (2013) 0.86
Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India. PLoS One (2013) 0.82
Occult hepatitis B viral infection among blood donors in South-Eastern Nigeria. Pathog Glob Health (2014) 0.81
Hepatitis B virus genetic mutations and evolution in liver diseases. World J Gastroenterol (2014) 0.80
Prevention of post-transfusion hepatitis by screening of antibody to hepatitis B core antigen in healthy blood donors. Mediterr J Hematol Infect Dis (2011) 0.80
Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy. Vox Sang (2014) 0.78
Evolution of Hepatitis B Virus in a Chronic HBV-Infected Patient over 2 Years. Hepat Res Treat (2011) 0.78
Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples. Blood Transfus (2014) 0.77
Characterization of the occult hepatitis B virus variants circulating among the blood donors from eastern India. ScientificWorldJournal (2013) 0.76
HBsAg Positive Patient Characteristics in Hospital and Blood Donation Camps. ISRN Hematol (2013) 0.75
Quantitation of HBV DNA; another modification of the test: Will it withstand the test of time? Indian J Hum Genet (2011) 0.75
Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses. Indian J Med Paediatr Oncol (2016) 0.75
Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health (2016) 0.75
Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India. PLoS One (2017) 0.75
Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J (2016) 0.75
Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India. Indian J Med Res (2016) 0.75
The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City. Jundishapur J Microbiol (2016) 0.75
Avoiding false positives with PCR. Nature (1989) 30.66
Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol (2002) 4.22
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology (2004) 4.12
Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol (2007) 2.96
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology (2004) 2.87
Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol (1999) 2.46
Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol (2002) 2.43
Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion (2001) 2.16
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion (2003) 2.00
Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med (2007) 1.97
Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol (1992) 1.94
Occult hepatitis B virus infection: implications in transfusion. Vox Sang (2004) 1.85
Occult hepatitis B virus infection and its clinical implications. J Viral Hepat (2002) 1.82
Epidemiology of hepatitis B virus infection in India. Gut (1996) 1.64
Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion (2003) 1.63
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology (2001) 1.61
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat (2005) 1.59
Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion (2007) 1.32
Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol (2001) 1.23
Hepatitis B virus genotypes and serotypes in western India: lack of clinical significance. J Med Virol (2003) 1.23
Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol (2006) 1.21
Anti-HBc screening in Indian blood donors: still an unresolved issue. World J Gastroenterol (2008) 1.19
Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA (2007) 1.17
Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India. Clin Infect Dis (2004) 1.11
Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat (2009) 1.06
Distribution of hepatitis B virus genotypes: phylogenetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, Eastern India. World J Gastroenterol (2006) 1.03
HIV, hepatitis B and C infection status of the blood donors in a blood bank of a tertiary health care centre of Orissa. Indian J Public Health (2008) 1.03
Hepatitis B virus genotypes in chronic liver disease patients from New Delhi, India. World J Gastroenterol (2006) 1.01
Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol (2004) 1.00
Nucleic acid sequence analysis of basal core promoter/precore/core region of hepatitis B virus isolated from chronic carriers of the virus from Kolkata, eastern India: low frequency of mutation in the precore region. Intervirology (2005) 0.99
Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common "a" determinant. Am J Gastroenterol (2000) 0.98
Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India. J Clin Virol (2007) 0.98
Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion. Transfusion (2006) 0.94
Occult hepatitis B virus (HBV) infection in healthy blood donors. Indian J Pathol Microbiol (2003) 0.92
Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol (2007) 0.87
Prevalent HBV genotypes and subtypes in a South Indian population. J Clin Virol (2006) 0.83
Fatal outcome of a hepatitis B virus transfusion-transmitted infection. Vox Sang (2010) 0.81
Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol (2007) 2.96
Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins. J Infect Dis (2010) 1.30
Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol (2006) 1.21
Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol (2006) 1.20
Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol (2005) 1.15
HIV type 1 subtypes circulating in eastern and northeastern regions of India. AIDS Res Hum Retroviruses (2002) 1.14
Recent pattern of Co-infection amongst HIV seropositive individuals in tertiary care hospital, Kolkata. Virol J (2011) 1.12
Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway. Virol J (2010) 1.08
Comparative evaluation of real-time PCR and conventional RT-PCR during a 2 year surveillance for influenza and respiratory syncytial virus among children with acute respiratory infections in Kolkata, India, reveals a distinct seasonality of infection. J Med Microbiol (2009) 1.07
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology (2011) 1.06
Distribution of hepatitis B virus genotypes: phylogenetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, Eastern India. World J Gastroenterol (2006) 1.03
Variations in the functional domain of basal core promoter of hepatitis B virus among Eastern Indian patients with prevalence of genotypes A, C, and D among the same ethnic population. J Med Virol (2011) 1.00
Nucleic acid sequence analysis of basal core promoter/precore/core region of hepatitis B virus isolated from chronic carriers of the virus from Kolkata, eastern India: low frequency of mutation in the precore region. Intervirology (2005) 0.99
Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India. J Clin Virol (2007) 0.98
Hepatitis C virus core protein interacts with fibrinogen-beta and attenuates cytokine stimulated acute-phase response. Hepatology (2010) 0.95
Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development. Indian J Med Res (2005) 0.95
Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes (2009) 0.95
Frequency and distribution of hepatitis B virus genotypes among eastern Indian voluntary blood donors: Association with precore and basal core promoter mutations. Hepatol Res (2008) 0.94
Molecular characterization and comparative analysis of pandemic H1N1/2009 strains with co-circulating seasonal H1N1/2009 strains from eastern India. Arch Virol (2010) 0.93
Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario. Virol J (2010) 0.93
Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers. Virology (2008) 0.93
Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1. Virol J (2011) 0.93
Drug trafficking routes and hepatitis B in injection drug users, Manipur, India. Emerg Infect Dis (2006) 0.90
Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients. Virology (2012) 0.90
A molecular approach (multiplex polymerase chain reaction) for diagnosis of rhinosporidiosis. Indian J Otolaryngol Head Neck Surg (2002) 0.90
Development of a new sensitive and efficient multiplex polymerase chain reaction (PCR) for identification and differentiation of different mycobacterial species. Trop Med Int Health (2003) 0.90
Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India. Infect Genet Evol (2010) 0.90
Development and optimization of nanosomal formulations for siRNA delivery to the liver. Eur J Pharm Biopharm (2011) 0.89
Molecular epidemiology and clinical significance of hepatitis B virus genotypes, core promoter and precore mutations in eastern India. Intervirology (2008) 0.88
G1862T mutation among hepatitis B virus-infected individuals: association with viral genotypes and disease outcome in Kolkata, Eastern India. Intervirology (2007) 0.88
Differential pattern of pre-S mutations/deletions and its association with hepatitis B virus genotypes in Eastern India. Infect Genet Evol (2012) 0.88
Molecular evidence for the occurrence of Japanese encephalitis virus genotype I and III infection associated with acute encephalitis in patients of West Bengal, India, 2010. Virol J (2012) 0.87
Determination of gag and env subtypes of HIV-1 detected among injecting drug users (IDUs) in Manipur, India: evidence for intersubtype recombination. Virus Res (2005) 0.87
Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol (2007) 0.87
Phylogenetic analysis of hepatitis B virus in Pakistan. J Coll Physicians Surg Pak (2008) 0.87
Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics. Mol Cell Biochem (2011) 0.87
Implementation of a multiregion hybridization assay to characterize HIV-1 strains detected among injecting drug users in Manipur, India. Intervirology (2009) 0.86
Phylogenetic analysis of env, gag, and tat genes of HIV type 1 detected among the injecting drug users in West Bengal, India. AIDS Res Hum Retroviruses (2006) 0.86
Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes. BMC Cancer (2014) 0.85
A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection. PLoS One (2011) 0.85
Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals. World J Gastroenterol (2011) 0.84
Silicene beyond mono-layers--different stacking configurations and their properties. J Phys Condens Matter (2013) 0.84
Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture. Virol J (2012) 0.84
Distribution of rotavirus VP7 genotypes among children suffering from watery diarrhea in Kolkata, India. Virus Res (2002) 0.83
Stability of lyophilized siRNA nanosome formulations. Int J Pharm (2011) 0.83
Development of rapid, sensitive one-tube duplex RT-PCR assay for specific and differential diagnosis of Chikungunya and dengue. J Virol Methods (2013) 0.83
SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells. PLoS One (2010) 0.83
Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication. Virol J (2010) 0.83
Evaluation of the wound healing activity of Shorea robusta, an Indian ethnomedicine, and its isolated constituent(s) in topical formulation. J Ethnopharmacol (2013) 0.82
Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India. PLoS One (2013) 0.82
Pin1-HBx interaction: a step toward understanding the significance of hepatitis B virus genotypes in hepatocarcinogenesis. Gastroenterology (2007) 0.82
Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation. PLoS One (2013) 0.82